Profiling the immune landscape in mucinous ovarian carcinoma
Nicola S. Meagher(The University of Sydney), Susan J. Ramus(Cancer Institute of New South Wales), Francisco José Cândido dos Reis(Universidade de São Paulo), Jennifer Alsop(Manchester Academic Health Science Centre), Angela Brooks‐Wilson(BC Cancer Agency), Derek S. Chiu(University of British Columbia), Anthony N. Karnezis(University of California Davis Medical Center), Linda S. Cook, Michael Friedländer(Prince of Wales Hospital), Christiani Bisinoto(Universidade de São Paulo), Kara L. Cushing‐Haugen(Fred Hutch Cancer Center), Anna DeFazio(The University of Sydney), David D.L. Bowtell(The University of Melbourne), Michael S. Anglesio(University of British Columbia), Marjorie J. Riggan(Duke Medical Center), C. Blake Gilks(Vancouver General Hospital), Ashley Weir(The University of Melbourne), Martin Widschwendter(Universität Innsbruck), Simon A. Gayther(The University of Texas Health Science Center at Houston), Catherine J. Kennedy(The University of Sydney), Aleksandra Gentry‐Maharaj(UCL Australia), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Phineas T. Hamilton, Shelby Thornton(BC Cancer Agency), Sián Fereday(Peter MacCallum Cancer Centre), Brad H. Nelson(University of British Columbia), Renée T. Fortner(Norwegian Institute of Public Health), Holly R. Harris(Fred Hutch Cancer Center), Katy Milne(University of Victoria), Malcolm C. Pike(Kettering University), Mitul Shah(University of Cambridge), Jennifer A. Doherty(Cancer Prevention Institute of California), Dale W. Garsed(Peter MacCallum Cancer Centre), Aline Talhouk(University of British Columbia), Usha Menon(University of South Florida), Naveena Singh(University of British Columbia), David G. Huntsman(BC Cancer Agency), Martin Köbel(University of Calgary), Paul D.P. Pharoah(Cedars-Sinai Medical Center), María J. García(Spanish National Cancer Research Centre), Anna Piskorz(Cancer Research UK Cambridge Center), Bronwyn Harris(University of Warwick), Celeste Leigh Pearce(University of Southern California), Nhu D. Le(BC Cancer Agency), Mercedes Jimenez‐Liñan(University of Kansas)
Cited by 26
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k